Non-Invasive Aesthetic Treatment Market Analysis

The Non-Invasive Aesthetic Treatment Market was valued at US$ 65.65 Billion in 2023, and it is projected to grow at a remarkable CAGR of 14.43% from 2024 to 2032, reaching US$ 220.84 Billion by 2032. This growth highlights a growing consumer preference for non-invasive procedures that enhance appearance without the need for surgery.

Understanding Non-Invasive Treatments

Non-invasive aesthetic treatments are procedures that do not involve surgery or the removal of tissues. With aging associated with visible signs such as age spots, sagging skin, and wrinkles, many individuals seek ways to rejuvenate their appearance. Non-invasive cosmetic procedures—like chemical peels, hyaluronic acid injections, and botulinum toxin treatments—offer effective solutions with minimal recovery time, fewer side effects, and no scarring, making them increasingly popular among patients.

Market Trends Driving Growth

Increasing Urge to Appear Attractive

The rise of social media has amplified the importance of physical appearance in both social and professional settings. Individuals, particularly millennials and Generation Z, are increasingly seeking non-surgical methods to enhance their looks.

• According to the International Society of Aesthetic Plastic Surgery (ISAPS), over 18.8 million non-surgical procedures were performed globally in 2022.
• Botulinum toxin procedures topped the list, with more than 9.2 million treatments, followed by hyaluronic acid with 4.3 million procedures.

Technological Advancements

Advancements in technology have significantly improved the effectiveness and accessibility of non-invasive treatments. Innovative devices utilizing radiofrequency, ultrasound, light, and laser technologies allow for effective treatments without the need for anesthesia, reducing risks and speeding up recovery times.

• Lumenis Ltd launched the NuEra Tight treatment in August 2020, which utilizes advanced technology for skin tightening without invasive procedures.
• Alma Lasers introduced the Harmony XL Pro, a versatile device for various non-invasive treatments.

Regional Market Insights

North America

The United States leads the global market for non-invasive aesthetic treatments, driven by a high acceptance rate of advanced technologies among its population. The increasing demand for cosmetic procedures, particularly among an aging population with disposable income, has fueled market growth.

• The U.S. performed 5,802,761 non-surgical procedures in 2022, maintaining its position as the top country for these treatments.

Asia Pacific

The Asia Pacific region is anticipated to be a lucrative market due to its large youth demographic and growing aging population. Enhanced awareness of non-invasive treatments and rising living standards are expected to drive growth in this area.

• By 2050, it's estimated that around 80% of the world’s elderly population will reside in low- and middle-income countries, presenting significant market opportunities.

Key Players in the Market

Prominent companies in the non-invasive aesthetic treatment sector include:

• Johnson & Johnson
• Bausch Health Companies Inc.
• Cutera Inc.
• AbbVie Inc.
• Sisram Medical Ltd.
• Galderma S.A.
• Sientra Inc.
• Revance Therapeutics Inc.

Recent Developments

• Feb 2024: Aesthetic Management Partners launched Plasmage, a fractional plasma device for precise skin treatment.
• Jan 2024: Empower Aesthetics announced a partnership with AW Skin Co. to enhance service offerings.
• Jan 2021: AbbVie introduced CoolSculpting Elite, a next-generation fat-reduction device.

Market Segmentation

1.    By Procedure:

o   Injectables

o   Skin Rejuvenation

o   Others

2.    Injectables Breakdown:

o   Botulinum Toxin

o   Hyaluronic Acid

o   Calcium Hydroxylapatite

o   Poly-L-Lactic Acid

3.    Skin Rejuvenation Breakdown:

o   Photo Rejuvenation

o   Chemical Peel

o   Micro Ablative Resurfacing

o   Full Field Ablative

4.    Others:

o   Hair Removal

o   Non-Surgical Fat Reduction

5.    Gender:

o   Male

o   Female

6.    End User:

o   Hospital/Surgery Centre

o   MedSpa

o   Traditional Spa

o   HCP Owned Clinic

7.    Geographical Breakdown:

o   United States

o   Brazil

o   Mexico

o   Germany

o   United Kingdom

o   Japan

o   India

o   And more.

Related Reports

Self-Monitoring Blood Glucose Device Market, Forecast 2024-2032

The global self-monitoring blood glucose device market is projected to reach approximately US$ 21.05 billion by 2032, growing at a CAGR of 6.76% from 2024 to 2032. The market includes products like test strips, lancets, and blood glucose meters, catering to various applications such as Type 1, Type 2, and gestational diabetes. With rising diabetes cases and technological advancements in diabetes management, this market is rapidly expanding.

Photodynamic Therapy Market, Size, Global Forecast 2024-2032

The photodynamic therapy market is anticipated to grow from US$ 3.63 billion in 2023 to US$ 6.97 billion by 2032, at a CAGR of 7.52%. This innovative cancer treatment utilizes photosensitizers activated by light to selectively destroy tumor cells. The increasing incidence of skin cancers and advancements in medical technology are significant drivers behind this growth.

United States Contact Lenses Market Forecast 2024-2032

The United States contact lenses market is expected to experience robust growth, driven by factors such as increasing myopia rates, technological advancements in lens materials, and rising awareness about eye health. The market is projected to expand significantly from 2024 to 2032, reflecting changing consumer preferences and innovations in product offerings.

About Us

Renub Research is a premier Market Research and Advisory company with over 15 years of experience in Business-to-Business Global Market Research, Business Surveys & Management Consulting. The services provided by our firm include a wide range of specific business research services designed to help firms in making sound business decisions.

We work together with our clients to determine their greatest potential and to solve the issues that the organizations face most urgently, as well as the alterations that are required for them. The clients of Interface include the top organizations around the world in sensitive industries like Healthcare, Travel & Tourism, food & beverages, Power & Energy, Information Technology Telecoms & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction and Agriculture.

Clients rely on our detailed market information and market data to enable decisions that are based on both information and knowledge. Renub Research is well established in providing extensive industry solutions, where our sensible study aids consultants, bankers, and executives to have a good industrial plan and taking sound business decisions.

Our team consist of professional and highly skilled personnel with education and experience in field of finance, marketing, human resource, biotechnology, pharmaceuticals IT, Environmental science and other related fields. Our findings of the studies that we have conducted are the basis of all management decisions; these include strategies, organizational chart, activities, use of technology, and merger and acquisition opportunities. It is with great pleasure that we support a great number of top global players that receive not only IT solutions but also complete overviews of opportunities and trends in different markets. Some of the characteristics of our research reports include information and insight, analysis and understanding, and forecast and estimation, all of which are important tools for managers in the contemporary cutthroat global economy.